Chiesi USA Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chiesi USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3298
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chiesi USA Inc (Chiesi USA), a subsidiary of Chiesi Farmaceutici S.p.A, is a specialty pharmaceutical company. It researches, develops, produces and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease and special care therapeutics. The company’s product portfolio comprises Cardene I.V. (nicardipine hydrochloride); Curosurf (poractant alfa); Zyflo (zileuton), Argatroban injection (Argatroban); Bethkis (tobramycin) and Retavase (reteplase). It offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems and specialty pharmacies.Chiesi USA is headquartered in Cary, North Carolina, the US.

Chiesi USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chiesi USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Chiesi Farmaceutici Acquires Cardiovascular Assets of The Medicines Company for up to USD743.8 Million 10
Licensing Agreements 12
Palladio Biosciences Enters into Agreement with Chiesi USA 12
Cornerstone Therapeutics Enters Into Licensing Agreement With Chiesi Farmaceutici For Bethkis 13
Cornerstone Enters Into Licensing Agreement With Digestive Care For Pertzye 14
Asset Transactions 15
Neos Therapeutics Acquires Tussionex from Chiesi and Coating Place 15
Merus Labs International Acquires North America Rights Of FACTIVE Tablets From Cornerstone Therapeutics 16
Acquisition 17
Chiesi Farmaceutici Completes Acquisition Of Remaining 42% Stake In Cornerstone Therapeutics For US$255 Million 17
Cornerstone Therapeutics Completes Acquisition Of EKR Therapeutics For Up To US$150 Million 19
Cornerstone Therapeutics Acquires Pharma Company, Cardiokine 21
Chiesi USA Inc – Key Competitors 22
Chiesi USA Inc – Key Employees 23
Chiesi USA Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
May 21, 2018: Triangle Business Journal Awards Chiesi USA, Inc. Second Consecutive Corporate Philanthropy Award 25
Government and Public Interest 26
May 03, 2018: NCBiotech Awards $2.65 Million in Grants, Loans in Two Latest Quarters 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Chiesi USA Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chiesi USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chiesi USA Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chiesi Farmaceutici Acquires Cardiovascular Assets of The Medicines Company for up to USD743.8 Million 10
Palladio Biosciences Enters into Agreement with Chiesi USA 12
Cornerstone Therapeutics Enters Into Licensing Agreement With Chiesi Farmaceutici For Bethkis 13
Cornerstone Enters Into Licensing Agreement With Digestive Care For Pertzye 14
Neos Therapeutics Acquires Tussionex from Chiesi and Coating Place 15
Merus Labs International Acquires North America Rights Of FACTIVE Tablets From Cornerstone Therapeutics 16
Chiesi Farmaceutici Completes Acquisition Of Remaining 42% Stake In Cornerstone Therapeutics For US$255 Million 17
Cornerstone Therapeutics Completes Acquisition Of EKR Therapeutics For Up To US$150 Million 19
Cornerstone Therapeutics Acquires Pharma Company, Cardiokine 21
Chiesi USA Inc, Key Competitors 22
Chiesi USA Inc, Key Employees 23
Chiesi USA Inc, Subsidiaries 24

List of Figures
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Chiesi USA Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ContourGlobal plc (GLO):企業の財務・戦略的SWOT分析
    ContourGlobal plc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Genesis Energy LP (GEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy LP (Genesis) is a midstream oil and gas company. The company provides services such as offshore pipeline transportation, refinery services, marine transportation, and onshore facilities and transportation. It purchases, transports, stores, blends, and markets crude oil and ref …
  • SINTEF:企業の戦略的SWOT分析
    SINTEF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Centrais Eletricas de Santa Catarina S.A. (CLSC4):企業の財務・戦略的SWOT分析
    Centrais Eletricas de Santa Catarina S.A. (CLSC4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Cosucra Groupe Warcoing SA:戦略・SWOT・企業財務分析
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Numaligarh Refinery Ltd:企業の戦略的SWOT分析
    Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Fugro NV (FUR):電力:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • Abreos Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Tutunski Kombinat AD Prilep:企業の戦略・SWOT・財務分析
    Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report Summary Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GigaGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GigaGen Inc (GigaGen) is a pre-clinical biotherapeutics company that develops antibody therapies to treat diseases of immune dysregulation. The company discovers and develops monoclonal and polyclonal antibody therapies and T cell therapies derived from immune repertoires. Its single cell se …
  • Vattenfall AB.:企業の戦略・SWOT・財務分析
    Vattenfall AB. - Strategy, SWOT and Corporate Finance Report Summary Vattenfall AB. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Lietuvos Draudimas AB:企業の戦略的SWOT分析
    Lietuvos Draudimas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Fast Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    Fast Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fast Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sequenom Inc-医療機器分野:企業M&A・提携分析
    Summary Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical labor …
  • China Medical System Holdings Ltd (867):企業の財務・戦略的SWOT分析
    Summary China Medical System Holdings Ltd (CMS),subsidiary of Treasure Sea Ltd, is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. It offers products various such as deanxit, ursofalk, augentropfen stulln mono eye-dr …
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆